Chemoinformaics analysis of 2,2,3-Trimethyl-3-cyclopentene-1-acetaldehyde
| Molecular Weight | 138.21 | nRot | 1 |
| Heavy Atom Molecular Weight | 124.098 | nRig | 6 |
| Exact Molecular Weight | 138.104 | nRing | 1 |
| Solubility: LogS | -2.472 | nHRing | 0 |
| Solubility: LogP | 2.42 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 25.1671 |
| nHD | 0 | BPOL | 14.9129 |
| QED | 0.401 |
| Synth | 3.783 |
| Natural Product Likeliness | 2.403 |
| NR-PPAR-gamma | 0.374 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.32 |
| MDCK | 0.0000242 |
| BBB | 0.77 |
| PPB | 0.545822 |
| VDSS | 3.447 |
| FU | 0.443366 |
| CYP1A2-inh | 0.06 |
| CYP1A2-sub | 0.307 |
| CYP2c19-inh | 0.038 |
| CYP2c19-sub | 0.799 |
| CYP2c9-inh | 0.011 |
| CYP2c9-sub | 0.722 |
| CYP2d6-inh | 0.025 |
| CYP2d6-sub | 0.491 |
| CYP3a4-inh | 0.033 |
| CYP3a4-sub | 0.28 |
| CL | 10.349 |
| T12 | 0.422 |
| hERG | 0.004 |
| Ames | 0.012 |
| ROA | 0.016 |
| SkinSen | 0.951 |
| Carcinogencity | 0.673 |
| EI | 0.991 |
| Respiratory | 0.579 |
| NR-Aromatase | 0.033 |
| Antiviral | No |
| Prediction | 0.949797 |